Pharmaceutical News

More Pharmaceutical News >

In Brief

Privately-held US biopharma Bluejay Therapeutics has announced that its lead product candidate brelovitug—also known as BJT-778—has received US Food and Drug Administration Breakthrough Therapy designation for the treatment of chronic hepatitis D.   22 January 2025
More Pharmaceutical News In Brief >

Mergers and Acquisitions

India’s Sun Pharmaceutical Industries announced that its subsidiary, Taro Pharmaceuticals, has entered into an agreement to acquire a 100 per cent stake in Antibe Therapeutics, a clinical-stage biotechnology company based in Ontario, Canada.   20 January 2025

More Pharmaceutical News M&A >

Boardroom

Neurocrine Biosciences has announced the appointment of Andrew Ratz as senior VP of drug development, supporting the firm’s expanding R&D efforts.   24 January 2025
UK clinical-stage specialty pharma firm Actimed Therapeutics has appointed Dr Fabio Dorigotti as chief medical officer (CMO) following the retirement of previous CMO, Dr Frank Misselwitz.   16 January 2025
Boston, USA-based Verastem Oncology today announced the appointment of Matthew Ros as chief operating officer (COO).   15 January 2025
French independent pharma company Servier says it has appointed David Lee to its executive committee as executive vice president for the United States, effective January 1, 2025.   13 January 2025
More Pharmaceutical News In The Boardrom >